Coherus BioSciences Inc
NASDAQ:CHRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
US |
|
Noxopharm Ltd
ASX:NOX
|
AU |
|
Red 5 Ltd
ASX:RED
|
AU |
|
W
|
Welsbach Technology Metals Acquisition Corp
NASDAQ:WTMA
|
US |
|
Indonesian Paradise Property Tbk PT
IDX:INPP
|
ID |
|
Select Sands Corp
XTSX:SNS
|
CA |
|
T
|
Technology Minerals PLC
LSE:TM1
|
UK |
Wall Street
Price Targets
CHRS Price Targets Summary
Coherus BioSciences Inc
According to Wall Street analysts, the average 1-year price target for
CHRS
is 5.78 USD
with a low forecast of 4.04 USD and a high forecast of 7.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CHRS's stock price target?
Price Target
5.78
USD
According to Wall Street analysts, the average 1-year price target for
CHRS
is 5.78 USD
with a low forecast of 4.04 USD and a high forecast of 7.35 USD.
What is Coherus BioSciences Inc's Revenue forecast?
Projected CAGR
65%
For the last 12 years the
compound annual growth rate for
Coherus BioSciences Inc's revenue is
25%.
The projected
CAGR
for the next 3 years is
65%.
